Tribromoacetic Acid

Tribromoacetic Acid

SCHEMBL2079154

O=C([O-])C(Br)(Br)Br.O=C([O-])C(F)(F)F.[K+].[Na+]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Tribromoacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.39
FAHD1 Q6P587 1/20 0.39
MEN1 O00255 1/20 0.33
LDHA P00338 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.33
CASP1 P29466 1/20 0.32
CA1 P00915 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL108536 0.84
Trifluoroacetic Acid SCHEMBL96619 0.84
Trifluoroacetic Acid SCHEMBL1332461 0.84
Tribromoacetic Acid SCHEMBL2076262 0.84
Tribromoacetic Acid SCHEMBL9710919 0.84
Potassium Ion SCHEMBL28700682 0.81 CA4 (0.44) CA4FAHD1MEN1LDHABLM
Trifluoroacetic Acid SCHEMBL31484359 0.81 CA4 (0.43) CA4FAHD1MEN1LDHABLM
Trifluoroacetic Acid SCHEMBL29424398 0.81 CA4 (0.43) CA4FAHD1MEN1LDHABLM
Trifluoroacetic Acid SCHEMBL3363842 0.81 CA4 (0.43) CA4FAHD1MEN1LDHABLM
Trifluoroacetic Acid SCHEMBL3920984 0.81 CA4 (0.40) CA4FAHD1MEN1LDHABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090012303-A1 CLEAN, HIGH-YIELD PREPARATION OF S,S AND R,S AMINO ACID ISOSTERES AEROJET FINE CHEMICALS LLC (US) 2009-01-08 US claimed
US-6867311-B2 Clean, high-yield preparation of S,S and R,S amino acid isosteres AEROJET FINE CHEMICALS LLC (US) 2005-03-15 US claimed
US-20030225292-A1 Clean, high-yield preparation of S,S and R,S amino acid isosteres AEROJET FINE CHEMICALS LLC, A DELAWARE LIMITED LIABILITY COMPANY 2003-12-04 US claimed
US-20130116457-A1 CLEAN, HIGH-YIELD PREPARATION OF S,S AND R,S AMINO ACID ISOSTERES AEROJET FINE CHEMICALS LLC (US) 2013-05-09 US disclosed
US-8163933-B2 Clean, high-yield preparation of S,S and R,S amino acid isosteres AMPAC FINE CHEMICALS LLC (US) 2012-04-24 US disclosed
US-20090012303-A1 CLEAN, HIGH-YIELD PREPARATION OF S,S AND R,S AMINO ACID ISOSTERES AEROJET FINE CHEMICALS LLC (US) 2009-01-08 US disclosed
US-7309803-B2 Clean, High-yield preparation of S,S and R,S amino acid isosteres AEROJET FINE CHEMICALS LLC (US) 2007-12-18 US disclosed
US-20050171170-A1 Clean, high-yield preparation of S,S and R,S amino acid isosteres AEROJET FINE CHEMICALS LLC, A DELAWARE LIMITED LIABILITY COMPANY (US) 2005-08-04 US disclosed
US-6867311-B2 Clean, high-yield preparation of S,S and R,S amino acid isosteres AEROJET FINE CHEMICALS LLC (US) 2005-03-15 US disclosed
US-20030225292-A1 Clean, high-yield preparation of S,S and R,S amino acid isosteres AEROJET FINE CHEMICALS LLC, A DELAWARE LIMITED LIABILITY COMPANY 2003-12-04 US disclosed
US-6605732-B1 Clean, high-yield preparation of S,S and R,S amino acid isosteres AEROJET FINE CHEMICALS LLC 2003-08-12 US disclosed
EP-1050532-A2 Preparation of S,S and R,S amino acid isosteres Aerojet Fine Chemicals LLC (US) 2000-11-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012303-A1 CLEAN, HIGH-YIELD PREPARATION OF S,S AND R,S AMINO ACID ISOSTERES SRMS, HCK, BHMT2 CA4 4042/4885FAHD1 3031/4885MEN1 2911/4885
US-20050171170-A1 Clean, high-yield preparation of S,S and R,S amino acid isosteres SRMS, HCK, BHMT2 CA4 3919/4885FAHD1 2941/4885MEN1 2891/4885
US-20130116457-A1 CLEAN, HIGH-YIELD PREPARATION OF S,S AND R,S AMINO ACID ISOSTERES SRMS, HCK, BHMT2 CA4 4042/4885FAHD1 3031/4885MEN1 2911/4885
US-20030225292-A1 Clean, high-yield preparation of S,S and R,S amino acid isosteres SRMS, HCK, BHMT2 CA4 3919/4885FAHD1 2941/4885MEN1 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.